AMIORG
vs
BSE Sensex 30

Over the past 12 months, AMIORG has underperformed BSE Sensex 30, delivering a return of -12% compared to the BSE Sensex 30's 7% growth.
Stocks Performance
AMIORG vs BSE Sensex 30
Performance Gap
AMIORG vs BSE Sensex 30
Performance Gap
Performance By Year
AMIORG vs BSE Sensex 30
Ami Organics Ltd
Glance View
Ami Organics Ltd. engages in the development and commercialization of pharmaceutical intermediate products. The company is headquartered in Surat, Gujarat and currently employs 561 full-time employees. The company went IPO on 2021-09-14. These specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). The company manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. The company has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The firm supplies its products to more than 150 customers directly in India.